Actual Medicinal Product (AMP) Oxylan 30mg prolonged-release tablets (G.L. Pharma UK Ltd)

Stability Information

(Some stability information inherited from generic)

Stability
Medicines under this category can theoretically be used inside an MCA; however, mitigations may need to be considered.
Notes

Airtight container. Protect from light.

Provenance

Compatiblity recommendation derived from Napp Pharmaceuticals Ltd product.

Generic
Oxycodone
Formulation
Oxycodone 30mg modified-release tablets
  • Oxycodone
    • Oxycodone 30mg modified-release tablets

      • Oxylan 30mg prolonged-release tablets (G.L. Pharma UK Ltd)

Alternative Suppliers (16)

OxyContin 30mg modified-release tablets (Napp Pharmaceuticals Ltd)
Reltebon 30mg modified-release tablets (Accord-UK Ltd)
Oxeltra 30mg modified-release tablets (Wockhardt UK Ltd)
Longtec 30mg modified-release tablets (Qdem Pharmaceuticals Ltd)
Renocontin 30mg modified-release tablets (Glenmark Pharmaceuticals Europe Ltd)
Oxypro 30mg modified-release tablets (Ridge Pharma Ltd)
Ixyldone 30mg modified-release tablets (Morningside Healthcare Ltd)
OxyContin 30mg modified-release tablets (DE Pharmaceuticals)
Longtec 30mg modified-release tablets (Pilsco Ltd)
Longtec 30mg modified-release tablets (DE Pharmaceuticals)
Oxylan 30mg prolonged-release tablets (G.L. Pharma UK Ltd)
OxyContin 30mg modified-release tablets (Waymade Healthcare Plc)
Abtard 30mg modified-release tablets (Ethypharm UK Ltd)
Leveraxo 30mg modified-release tablets (Viatris UK Healthcare Ltd)
Oxycodone 30mg modified-release tablets (A A H Pharmaceuticals Ltd)
OxyContin 30mg modified-release tablets (Mawdsley-Brooks & Company Ltd)